Evaluating resmetirom eligibility among patients with metabolic dysfunction-associated steatohepatitis (MASH): insights from the German steatotic liver disease (SLD)-registry - Messer, E K; Petroff, D; Schattenberg, J M; Zeuzem, S; von der Ohe, M; Ludwig, L; Demir, M; Buggisch, P; Stein, K; Serfert, Y; Wedemeyer, H; Berg, T; Hofmann, W P; Geier, A; Wiegand, J (Zeitschrift für Gastroenterologie, 2025)